The role of MIG/CXCL9 in cardiac allograft vasculopathy.
about
Expression of allograft inflammatory factor-1 in T lymphocytes: a role in T-lymphocyte activation and proliferative arteriopathiesRecruitment of CXCR3+ and CCR5+ T cells and production of interferon-gamma-inducible chemokines in rejecting human arteries.Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection.T cells in cardiac allograft vasculopathy are skewed to memory Th-1 cells in the presence of a distinct Th-2 population.Isolation of scFv fragments specific for monokine induced by interferon-gamma (MIG) using phage display.CXCR3 ligands contribute to Th1-induced inflammation but not to homing of Th1 cells into the lung.CXC chemokine ligand (CXCL) 9 and CXCL10 are antagonistic costimulation molecules during the priming of alloreactive T cell effectorsImmunosuppression for lung transplantation.Novel CD8 T cell alloreactivities in CCR5-deficient recipients of class II MHC disparate kidney grafts.The chemokines CXCL9 and CXCL10 promote a protective immune response but do not contribute to cardiac inflammation following infection with Trypanosoma cruzi.Stem cell origins of intimal cells in graft arterial disease.Chemokine receptor-dependent alloresponses.Chemokines and transplant vasculopathy.Lessons and limits of mouse models.Cytokine networking of innate immunity cells: a potential target of therapy.CCR5 is required for regulation of alloreactive T-cell responses to single class II MHC-mismatched murine cardiac grafts.Small molecule CXCR3 antagonist NIBR2130 has only a limited impact on type 1 diabetes in a virus-induced mouse model.The chemokine receptor Cxcr3 is not essential for acute cardiac allograft rejection in mice and rats.Identification, functional analysis and expression in a heterotopic heart transplant model of CXCL9 in the rat.ImmunoFET feasibility in physiological salt environments.Macrophage depletion suppresses cardiac allograft vasculopathy in mice.
P2860
Q24310568-18D973C4-E37D-44FF-8863-7D3E242F5ECDQ33214938-F2F3C19C-DC87-4AD7-B86B-64102315F1BFQ33247068-8E38A806-3A8C-4C1D-B609-6A59C1A6AA98Q33328649-C19DA632-88F9-45A8-8541-2396F8C4437CQ33551911-21192B54-6C2C-4AA2-86EE-2C211C560636Q33646444-D3F3AA71-6E6E-4A37-A004-AD12DD5ED246Q33913346-501C4739-61CC-4866-B260-E5FFCA80E3B3Q33996931-8ED6ADDD-13E4-4321-A386-503F28A1D73AQ34218745-3C8F0E9D-0432-43D7-960A-19F447E0F887Q34301095-30859288-2E6B-428F-9FE6-B9124085375CQ35095437-FC09D797-720F-4251-9CDE-BE3F534D83E9Q35583497-1F8D87AE-C46A-476C-A0CC-54467DAA6852Q37256207-F5E12ABC-8725-44CB-8973-F675FF1BFC41Q37340373-8451C26E-1B21-441E-BBEB-405667BCA2DDQ38180799-5DB746E3-58E0-4EA3-9891-45A86079BA43Q41877633-5002DD5F-485D-4C85-A6E1-554A6E80D822Q45365916-6870AC2F-BC0B-48E1-BEF0-D6BFA6DD731CQ46537216-451CF4E2-19C3-4A27-A00A-C49C424E1103Q46932905-EC46E260-41FE-4C51-8AAA-748FE9898093Q47895377-BC66BA17-2F01-4A28-A6BD-309B3EEB84AEQ53522854-9CE36863-F317-46CB-AFB1-B23E010EAAC5
P2860
The role of MIG/CXCL9 in cardiac allograft vasculopathy.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
The role of MIG/CXCL9 in cardiac allograft vasculopathy.
@ast
The role of MIG/CXCL9 in cardiac allograft vasculopathy.
@en
type
label
The role of MIG/CXCL9 in cardiac allograft vasculopathy.
@ast
The role of MIG/CXCL9 in cardiac allograft vasculopathy.
@en
prefLabel
The role of MIG/CXCL9 in cardiac allograft vasculopathy.
@ast
The role of MIG/CXCL9 in cardiac allograft vasculopathy.
@en
P2093
P2860
P1476
The role of MIG/CXCL9 in cardiac allograft vasculopathy.
@en
P2093
Abbas Ardehali
David Whiting
Hillel Laks
James J Yun
John Belperio
Judith A Berliner
Marie D Burdick
Michael C Fishbein
Michael P Fischbein
Robert M Strieter
P2860
P304
P356
10.1016/S0002-9440(10)64407-0
P407
P577
2002-10-01T00:00:00Z